IL9 and colon carcinoma: In this setting, the importance of TH9 cell responses in mediating anti-tumor immunity following vaccination of CEA transgenic mice was shown by demonstrating that IL-9 neutralization prevents the ability of the vaccine to protect mice against a challenge of live colon carcinoma MC38.CEA cells.